CYTOKINETICS, INCORPORATED Finance Lease, Liability
CYTOKINETICS, INCORPORATED (CYTK) had Finance Lease, Liability of $204.00 thousand as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Balance Sheet › Liabilities › Debt
us-gaap:FinanceLeaseLiability · last filed 2025-02-27
- 2024-12-31: Finance Lease, Liability $204.00K.
- 2023-12-31: Finance Lease, Liability $1.14M.
- 2022-12-31: Finance Lease, Liability $2.00M.
- 2022-09-30: Finance Lease, Liability $2.20M.
| Period end | Finance Lease, Liability |
|---|---|
| 2024-12-31 | $204.00K 10-K · filed 2025-02-27 |
| 2023-12-31 | $1.14M 10-K · filed 2024-02-28 |
| 2022-12-31 | $2.00M 10-K · filed 2023-03-01 |
| 2022-09-30 | $2.20M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $2.47M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $2.28M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $1.30M 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |